Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chantry

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
ACS Omega|February 24, 2025
3,3'-Diindolylmethane (DIM): A Molecular Scaffold for Inhibition of WWP1 and WWP2, Members of the NEDD4 Family HECT E3 LigasesAshley P Dudey, Gregory R Hughes, Jake M Rigby, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 13, 2018
Discovery of Small Molecule WWP2 Ubiquitin Ligase InhibitorsJessica E Watt, Gregory R Hughes, Samuel Walpole, et al.
British Journal of Haematology|November 17, 2006
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myelomaEvangelos Terpos, Deborah J Heath, Amin Rahemtulla, et al.
International Journal of Cancer|January 19, 2007
Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivoClaire M Edwards, Gabrielle Mueller, Anke J Roelofs, et al.
British Journal of Haematology|July 30, 2015
Time to redefine MyelomaGuy Pratt, Stella Bowcock, Andrew Chantry, et al.
Plos One|July 4, 2008
Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostateMaria Traka, Amy V Gasper, Antonietta Melchini, et al.
Stem Cell Research & Therapy|December 1, 2020
ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formationDan Zhang, Kim De Veirman, Rong Fan, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myelomaRong Fan, Hatice Satilmis, Niels Vandewalle, et al.
British Journal of Haematology|June 11, 2021
Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory studyStuart Scott, Ashley Cartwright, Sebastian Francis, et al.
BMJ Open|November 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trialKara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
ACS Omega|February 24, 2025
3,3'-Diindolylmethane (DIM): A Molecular Scaffold for Inhibition of WWP1 and WWP2, Members of the NEDD4 Family HECT E3 LigasesAshley P Dudey, Gregory R Hughes, Jake M Rigby, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 13, 2018
Discovery of Small Molecule WWP2 Ubiquitin Ligase InhibitorsJessica E Watt, Gregory R Hughes, Samuel Walpole, et al.
British Journal of Haematology|November 17, 2006
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myelomaEvangelos Terpos, Deborah J Heath, Amin Rahemtulla, et al.
International Journal of Cancer|January 19, 2007
Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivoClaire M Edwards, Gabrielle Mueller, Anke J Roelofs, et al.
British Journal of Haematology|July 30, 2015
Time to redefine MyelomaGuy Pratt, Stella Bowcock, Andrew Chantry, et al.
Plos One|July 4, 2008
Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostateMaria Traka, Amy V Gasper, Antonietta Melchini, et al.
Stem Cell Research & Therapy|December 1, 2020
ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formationDan Zhang, Kim De Veirman, Rong Fan, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myelomaRong Fan, Hatice Satilmis, Niels Vandewalle, et al.
British Journal of Haematology|June 11, 2021
Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory studyStuart Scott, Ashley Cartwright, Sebastian Francis, et al.
BMJ Open|November 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trialKara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, et al.
Pageof 4